Page last updated: 2024-10-29

ketamine and Pyruvate Metabolism, Inborn Errors

ketamine has been researched along with Pyruvate Metabolism, Inborn Errors in 1 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Pyruvate Metabolism, Inborn Errors: Hereditary disorders of pyruvate metabolism. They are difficult to diagnose and describe because pyruvate is a key intermediate in glycolysis, gluconeogenesis, and the tricarboxylic acid cycle. Some inherited metabolic disorders may alter pyruvate metabolism indirectly. Disorders in pyruvate metabolism appear to lead to deficiencies in neurotransmitter synthesis and, consequently, to nervous system disorders.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Hau, V1
Bonilla-Velez, J1
Low, D1

Other Studies

1 other study available for ketamine and Pyruvate Metabolism, Inborn Errors

ArticleYear
Anesthesia management for ENT surgery in a child with X-linked pyruvate kinase deficiency.
    Paediatric anaesthesia, 2021, Volume: 31, Issue:4

    Topics: Anemia, Hemolytic, Congenital Nonspherocytic; Anesthesia; Anesthetics; Child; Dexmedetomidine; Human

2021